A Double-blind, Parallel-group Phase III Study of TK-041 in Patients with Seasonal Allergic Rhinitis
Phase 3
- Conditions
- Seasonal allergic rhinitis
- Registration Number
- JPRN-jRCT2080222733
- Lead Sponsor
- TEIKOKU SEIYAKU CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 900
Inclusion Criteria
Symptoms of allergic rhinitis in cedar pollen season for 2 years or longer
Exclusion Criteria
Nose diseases (nasal polypus, nasal septum curvature symptom, hypertrophic rhinitis, etc.) or infectious diseases (upper respiratory tract inflammation, sinusitis, infectious rhinitis, infectious ophthalmopathy, etc.) that may interfere with the evaluation
Hypersensitivity to antihistamine drugs or study drug
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method